TerminatedInterventionalPhase 4Updated Aug 22, 2023
Effect of Intraoperative Remifentanil Infusion Rate on Postoperative Tolerance and Analgesic Consumption in Pediatric Laparoscopic... | NCT01147757 | Trialant
Unknown statusInterventionalNot ApplicableUpdated Dec 6, 2011
Effect of Intraoperative Remifentanil Infusion Rate on Postoperative Tolerance and Analgesic Consumption in Pediatric Laparoscopic Ureteroneocystostomy
ClinicalTrials.gov ID
NCT01147757
Lead Sponsor
Yonsei UniversityOTHER
Overall Status
Unknown status
Study Type
Interventional
Phase
Not Applicable
Enrollment
60Estimated
Last Update Posted
Dec 6, 2011Estimated
Start Date
Jun 2010
Primary Completion Date
Jun 2012Estimated
Completion Date
Jun 2012Estimated
Brief Summary
Effect of intraoperative remifentanil infusion rate on postoperative tolerance and analgesic consumption in pediatric laparoscopic ureteroneocystostomy.
Pediatrics
remifentanil
Ages Eligible for Study
Child (0-17)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Pediatric patients (ASA physical status I and II) aged between 1-5 yrs and scheduled elective laparoscopic ureteroneocystostomy
Exclusion Criteria:
cardiovascular, renal, liver disease or growth retardation